American Journal of Cardiovascular Drugs

Acknowledgment
pp. 349-350(2)
Author: Adis International Limited,

ACE Inhibitors in Heart Failure: What More Do We Need to Know?
pp. 351-359(9)
Authors: Demers, Catherine; Mody, Anita; Teo, Koon K.; McKelvie, Robert S.

Pharmacological Management of Atrial Fibrillation following Cardiac Surgery
pp. 361-369(9)
Authors: Hilleman, Daniel E.; Hunter, Claire B.; Mohiuddin, Syed M.; Maciejewski, Stephanie

Antiarrhythmic Drugs in Patients with Implantable Cardioverter-Defibrillators
pp. 371-378(8)
Authors: Bollmann, Andreas; Husser, Daniela; Cannom, David S.

Beyond Low-Density Lipoprotein: Addressing the Atherogenic Lipid Triad in Type 2 Diabetes Mellitus and the Metabolic Syndrome
pp. 379-387(9)
Author: Nesto, Richard W.

Peroxisome Proliferator-Activated Receptor-γ and its Agonists in Hypertension and Atherosclerosis: Mechanisms and Clinical Implications
pp. 389-398(10)
Authors: Halabi, Carmen M.; Sigmund, Curt D.

The Role of the Platelet in the Pathogenesis of Atherothrombosis
pp. 399-408(10)
Authors: Steinhubl, Steven R.; Moliterno, David J.

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk
pp. 409-415(7)
Authors: Wolozinsky, Mia; Yavin, Yshai Y.; Cohen, Alexander T.